Tim Barabe

Track

Insider profile

Currently holds positions in Cartesian Therapeutics, Inc. and Veeva Systems Inc.

Performance

Overall performance
2.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 45% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
16 44% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -94%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director Cartesian Therapeutics, Inc. July 29, 2016 -
Independent Director Veeva Systems Inc. Sept. 10, 2015 -
Independent Director ArQule Inc Nov. 1, 2001 - Jan. 16, 2020
Chief Financial Officer, Executive Vice President Affymetrix Inc March 15, 2010 - May 20, 2013
Tim Barabe's trades of Cartesian Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
308.69
Quantity 1,292 -18.0%
Value US$398,827
Transaction date
Sale
Price
288.00
Quantity 952 -11.7%
Value US$274,176
Transaction date
Sale
Price
242.00
Quantity 347 -4.2%
Value US$83,974
Transaction date
Sale
Price
238.45
Quantity 1,428 -14.8%
Value US$340,509
Transaction date
Sale
Price
156.00
Quantity 347 -3.6%
Value US$54,132
Transaction date
Sale
Price
167.19
Quantity 727 -7.8%
Value US$121,549
Transaction date
Sale
Price
127.41
Quantity 727 -7.8%
Value US$92,623
Transaction date
Sale
Price
0.55
Quantity 7,809 -37.7%
Value US$4,302
Transaction date
Sale
Price
0.55
Quantity 7,105 -25.5%
Value US$3,908
Transaction date
Purchase
Price
1.15
Quantity 10,000 +166.7%
Value US$11,500
US ArQule Inc (ARQL)
Transaction date
Purchase
Price
6.01
Quantity 2,600 +63.4%
Value US$15,626
US ArQule Inc (ARQL)
Transaction date
Purchase
Price
6.00
Quantity 400 +10.8%
Value US$2,400
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-08 2025-12-04
B Purchase
79,803 +43.6%
389.80
US$3,178,351 		79,803 +43.6% 389.80 US$3,178,351
2024-08-14 2024-08-12
B Purchase
26,052 -25.5%
215.37
US$2,267,748 		26,052 -25.5% 215.37 US$2,267,748
2022-05-11 2022-05-09
B Purchase
5,955 -12.7%
196.79
US$2,516,956 		5,955 -12.7% 196.79 US$2,516,956
2021-03-30 2021-03-26
B Purchase
10,000 +5.8%
4.10
US$41,000 		10,000 +5.8% 4.10 US$41,000
2020-10-15 2020-10-13
S Sale
1,292 -18.0%
308.69
US$398,827 		1,292 -18.0% 308.69 US$398,827
2020-10-09 2020-10-08
S Sale
952 -11.7%
288.00
US$274,176 		952 -11.7% 288.00 US$274,176
2020-10-08 2020-10-06
B Purchase
50,000 +41.3%
1.68
US$83,985 		50,000 +41.3% 1.68 US$83,985
2020-06-24 2020-06-23
S Sale
347 -4.2%
242.00
US$83,974 		347 -4.2% 242.00 US$83,974
2020-06-24 2020-06-22
S Sale
1,428 -14.8%
238.45
US$340,509 		1,428 -14.8% 238.45 US$340,509
2020-04-09 2020-04-08
S Sale
347 -3.6%
156.00
US$54,132 		347 -3.6% 156.00 US$54,132
2020-03-19 2020-03-17
B Purchase
5,000 +6.0%
2.00
US$10,000 		5,000 +6.0% 2.00 US$10,000
2019-06-19 2019-06-18
S Sale
727 -7.8%
167.19
US$121,549 		727 -7.8% 167.19 US$121,549
2019-04-03 2019-04-02
S Sale
727 -7.8%
127.41
US$92,623 		727 -7.8% 127.41 US$92,623
2016-11-22 2016-11-18
S Sale
7,809 -37.7%
0.55
US$4,302 		7,809 -37.7% 0.55 US$4,302
2016-11-22 2016-11-18
S Sale
7,105 -25.5%
0.55
US$3,908 		7,105 -25.5% 0.55 US$3,908
2014-09-18 2014-09-17
B Purchase
10,000 +166.7%
1.15
US$11,500 		10,000 +166.7% 1.15 US$11,500
2004-05-25 2004-05-24
US ArQule Inc (ARQL)
B Purchase
2,600 +63.4%
6.01
US$15,626 		2,600 +63.4% 6.01 US$15,626
2004-05-25 2004-05-24
US ArQule Inc (ARQL)
B Purchase
400 +10.8%
6.00
US$2,400 		400 +10.8% 6.00 US$2,400